skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

New anticoagulants for the prevention and treatment of venous thromboembolism

(1890) Views  (326) Full article downloads

Authors: Simon J McRae, Jeffrey S Ginsberg

Published Date May 2005 Volume 2005:1(1) Pages 41 - 53
DOI: http://dx.doi.org/10.2147/VHRM.S

Simon J McRae, Jeffrey S Ginsberg

Department of Medicine, McMaster University, Hamilton, ON, Canada

Abstract: Anticoagulant therapy is effective at preventing the development of venous thromboembolism in high-risk patients, and reduces morbidity and mortality in individuals with established thromboembolic disease. Vitamin K antagonists and heparins are currently the most commonly used anticoagulant drugs, but they have practical limitations. Therefore, new antithrombotic agents with predictable dose-responses (thereby decreasing the need for monitoring without compromising efficacy or safety), ideally available in an oral formulation and with a rapidly reversible anticoagulant effect, are needed. New drugs fulfilling some of the above criteria have been developed and have proven to be effective agents for the treatment and prevention of venous thromboembolism.

Keywords: venous thromboembolism, anticoagulants, antithrombotic








Readers of this article also read:

Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
Periosteoplasty for covering gingival recessions: Clinical results
Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
A systematic writing program as a tool in the grief process: part 1
Erratum
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University